Sarepta stock crashed Tuesday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.

A groundbreaking new tool created by an international team of scientists could help doctors spot people at higher risk for ...

Discover Revvity, Inc.’s latest earnings, cloud growth, and $1B buyback. Click for my updated look at RVTY stock and why I ...

Procter & Gamble rises premarket after Q1 beat, productivity gains, raised EPS guidance, steady cash returns, modest sales ...

Incyte's growth potential and low valuation are driven by a strong pipeline and strategic focus. Read here for an investment analysis of INCY stock.

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Gene ...

Abstract: The Reentrant Flexible Flow Shop Scheduling Problem (RFFSP) involves multiple repetitions of job processing in the production system, which leads to higher scheduling complexity. To solve ...

Representatives from The Office for Women cannot recall any instance where a minister has asked them for feedback on third-party policy proposals on women’s issues. Coalition Senator Jane Hume asked ...

Growth charts for children with rare genetic disorders - giving healthcare professionals and families clearer guidance on how a child is developing - have been created by an international team, led by ...

Send us a tip using our anonymous form. A daily briefing on what matters in the music industry Send us a tip using our anonymous form. Billboard is a part of Penske ...